ALISTAIR IAN LONGSHAW,EUAN ALEXANDER FRASER FORDYCE,STUART THOMAS ONIONS,JOHN KING-UNDERWOOD,JENNIFER VENABLE
申请号：
US15457810
公开号：
US20170182039A1
申请日:
2017.03.13
申请国别(地区):
US
年份:
2017
代理人:
摘要：
A dry powder pharmaceutical formulation for inhalation including a compound of formula (I):that is 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)-3-(4-((2-((6-ethylpyrazin-2-yl)amino)pyridin-4-yl)methoxy)naphthalen-1-yl)urea or a pharmaceutically acceptable salt thereof, including all stereoisomers, tautomers and isotopic derivatives thereof； and lactose as a topically acceptable diluent. An inhaler device containing the dry powder pharmaceutical formulation is also described.
